A Retrospective Study of 320 Patients Treated with Carotid Artery Stenting at 4 General Hospitals in Zhejiang Province to Establish a Risk Score for Cerebral Hypoperfusion Syndrome

25 April 2022 : Clinical Research

Yuan Liu^1B, Changyang Zhong^1ABCEF*, Peng Wang^2BC, Jianhong Yang^3DF, Chenghua Xu^4BF, Zuyong Zhang^5AFG

DOI: 10.12659/MSM.935697

Med Sci Monit 2022; 28:e935697

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Incidence and clinical outcomes of CHS after carotid stenting.

	Number of cases	CHS occurrence number of cases (rate)	Clinical outcome (number of cases and percentage [%])
	Number of cases	CHS occurrence number of cases (rate)	Death	Disability	Recovery	Become better	Automatic discharge
Total number of cases	320	68 (21.25%)	6 (8.82)	26 (38.24)	10 (14.71)	19 (27.94)	7 (10.29)
Test set	225	47 (20.89%)	4 (8.51)	18 (38.30)	7 (14.89)	13 (27.66)	5 (10.64)
Validation set	95	21 (22.11%)	2 (9.52)	8 (38.10)	3 (14.29)	6 (28.57)	2 (9.52)
CHS – cerebral hypoperfusion syndrome.

Back to the Article